PERSPECTA

News from every angle

← Back to headlines

AgomAb Therapeutics (AGMB) Secures U.S. Patent for AGMB-447

AgomAb Therapeutics (AGMB) has been granted a U.S. patent for its compound AGMB-447.

12 Apr, 18:46 — 12 Apr, 18:46
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual17d ago

AgomAb Therapeutics (AGMB) Wins U.S. Patent for AGMB-447

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Philippine DOH Executive Faces Graft Complaint Over Brother's P140M Project

just now

Gen Z Navigates Work and Life Amid Constant Change

just now

Puerto Princesa Police Seize Smuggled Cigarettes

just now